Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-28

Clinical Trial Update: Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease Patients [NA]

View source ↗

Summary

This document provides an update on a clinical trial assessing the safety and efficacy of the orally administered NUV001 nutraceutical supplement in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NUV001

Snippet

Sponsor: LGD | Conditions: Sickle Cell Disease | NA | Status: ACTIVE_NOT_RECRUITING